GlassScriptPhysician profile
Dung Hoang
NPI 1902858962
$8,902.81
in general payments reported to CMS, 2019-2025
45 companies · $1,557 in 2025
The $1,557 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $1,136 · 2021: $1,516 · 2022: $1,085 · 2023: $1,609 · 2024: $1,364 · 2025: $1,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,530.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,024.13 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,349.06 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $823.80 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $658.32 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $536.37 | 2019-2024 | Jardiance |
| Pfizer INC. | $384.08 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $299.55 | 2021-2025 | |
| Exact Sciences Corporation | $292.88 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $274.92 | 2019-2024 | |
| Amgen INC. | $232.92 | 2020-2025 | Repatha, Otezla, Repatha |
| Allergan, INC. | $226.73 | 2019-2020 | |
| Abbott Laboratories | $218.85 | 2023-2025 | Freestyle Libre |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.82 | 2019-2025 | Xifaxan |
| Astellas Pharma US INC | $169.09 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $150.57 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dung Hoang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.